Intraoperative electron RT series reports 43% three-year survival after head and neck salvage surgery

In 127 previously irradiated head and neck cancer patients, surgery plus IOERT achieved median survival of 20.5 months without a comparator.

KEY POINTS

  • This retrospective single-institution study from The Ohio State University Comprehensive Cancer Center evaluated 127 patients with locoregionally recurrent or persistent head and neck cancer who underwent salvage surgery combined with intraoperative electron radiation therapy (IOERT) between 1999 and 2023. All patients had previously received external beam radiotherapy, with 70 patients (55.1%) treated for persistent disease and 57 (44.9%) for recurrence after documented disease clearance. The cohort included 109 patients with squamous cell carcinoma (85.8%), and median follow-up was 70 months.
  • Initial radiotherapy had delivered a median dose of 66 Gy (IQR 60–70 Gy), with a median interval of 23 months (IQR 8–73 months) before salvage IOERT. The median intraoperative dose was 12.5 Gy (IQR 10–15 Gy; range 7.5–17.5 Gy), delivered using a mobile electron linear accelerator, most commonly with 6-MeV electrons (119/124 evaluable patients, 96%) and a 6-cm median applicator diameter. All patients underwent vascularized flap reconstruction. Following salvage surgery and IOERT, 51 patients (40%) received additional EBRT, with a median dose of 44 Gy, while 11 received concurrent chemotherapy with that course and 24 received immune checkpoint inhibitors at variable subsequent time points.
  • Median overall survival was 20.5 months (95% CI 14.6–40.2), with estimated survival rates of 63% at one year, 48% at two years, and 43% at three years. Median disease-free survival was 8.8 months (95% CI 7.2–12.2), with one- and three-year disease-free survival of 42% and 25%, respectively. These outcomes describe a highly selected population receiving intensive multimodality salvage treatment and cannot establish the survival contribution of IOERT independently of surgery, postoperative reirradiation, or systemic therapy.
  • Locoregional failure remained frequent despite salvage treatment. A total of 65 patients experienced locoregional recurrence or progression, including 21 local failures alone, 11 regional failures alone, and 33 combined local and regional failures. With death treated as a competing event, cumulative locoregional failure incidence reached 34.3% at one year, 44.7% at two years, and 49.8% at three years. Reliable classification of failures as occurring inside or outside the IOERT field was unavailable, limiting conclusions about the adequacy of intraoperative target coverage.
  • Distant failure was also an important and frequently early event. A total of 37 patients had documented distant progression, with 27 of these events (73%) occurring within the first year following IOERT. Median observed time to distant failure was 5.3 months, and cumulative distant failure incidence reached 21.6%, 24.0%, and 26.7% at one, two, and three years, respectively. These results highlight that additional local treatment alone may be insufficient for patients with aggressive disease biology and substantial systemic relapse risk.
  • Positive surgical margins and extranodal extension were associated with worse survival. Microscopic margin positivity was present in 60 patients (47.2%), while 22 (17.3%) had close but microscopically negative margins. In separate age- and sex-adjusted exploratory Cox models, positive margins were associated with higher mortality (HR 1.68, 95% CI 1.11–2.53; p=0.014), as was extranodal extension (HR 2.98, 95% CI 1.39–6.37; p=0.007). Patients with negative or close margins had median OS of 37 months versus 14.5 months with positive margins. Positive p16 status was associated with better survival (HR 0.51; p=0.033), but this analysis involved only 72 evaluable patients with mixed primary sites and histologies and was not restricted to oropharyngeal SCC.
  • Postoperative safety could not be comprehensively assessed because complication documentation was incomplete. Three patients died within 90 days (2.4%), including one fatal carotid rupture 18 days after surgery and two deaths attributed to sepsis. Among the 75 patients with available complication documentation, recorded events included six mucocutaneous complications, four dysphagia events, and one wound dehiscence with carotid dissection. Fistulas were documented in four patients, although one occurred on day 91 and the timing of the others was inconsistently recorded. Complication information was unavailable for 52/127 patients, preventing reliable estimation of grade 3–4 morbidity, while flap complications, late toxicity, cumulative OAR doses, and treatment-related functional outcomes were not systematically assessed.

CLINICAL TAKEAWAY

Salvage surgery combined with intraoperative electron radiotherapy achieved long-term survival in a subset of carefully selected patients with recurrent or persistent head and neck cancer after previous irradiation, but locoregional and distant failures remained common. Margin status and extranodal extension were associated with prognosis, while the absence of a surgery-only comparator, incomplete toxicity ascertainment, and heterogeneous additional treatments prevent conclusions about the independent effectiveness or comparative safety of IOERT.

SOURCE

Cancers

Browse more research Suggest a correction